Acetate salt is not N-terminal acetylation An acetate counterion is associated ionically with the peptide
At the 12 mg dose level, here is what clinical trials reported: Nausea: 43.2% of participants (versus 10.7% on placebo) Diarrhea: 33.1% of participants (versus 13.4% on placebo) Constipation: 25.0% of participants (versus 8.7% on placebo) Vomiting: 20.9% of participants These percentages tell an important story
The compound is referenced across a wide spectrum of preclinical models, with most literature focusing on three thematic areas: Skin biology: Studies on dermal fibroblast behaviour, collagen and elastin synthesis pathways, and extracellular matrix remodelling Gene expression modulation: Research examining the compounds reported activity across thousands of genes in genome-wide expression studies Antioxidant & copper transport: Models exploring its role as a physiological copper carrier and free radical interaction The 50mg and 100mg vial formats make GHK-Cu particularly suitable for extended research protocols where higher peptide volumes are required compared with the typical 510mg formats used for other research compounds
I write because it shows me how to love people, respect people, how to be a decent mother-fucker, you know
We are conveniently located at 15238 W Warren Ave Ste #A, Dearborn, MI 48126
